Musa Altun

911 total citations
33 papers, 740 citations indexed

About

Musa Altun is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Musa Altun has authored 33 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Otorhinolaryngology, 15 papers in Oncology and 13 papers in Surgery. Recurrent topics in Musa Altun's work include Head and Neck Cancer Studies (21 papers), Head and Neck Surgical Oncology (8 papers) and Lung Cancer Research Studies (4 papers). Musa Altun is often cited by papers focused on Head and Neck Cancer Studies (21 papers), Head and Neck Surgical Oncology (8 papers) and Lung Cancer Research Studies (4 papers). Musa Altun collaborates with scholars based in Türkiye, France and United States. Musa Altun's co-authors include Abderrahim Fandi, Esteban Cvitkovic, İnci̇ Ayan, P. Armand, F. Eschwège, Zdenko Krajina, Olivier Dupuis, Canan Alatlı, Merdan Fayda and Ahmet Karadeniz and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Endoscopy.

In The Last Decade

Musa Altun

29 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Musa Altun Türkiye	14	381	319	276	188	183	33	740
Tomohiro Enokida Japan	15	108 0.3×	333 1.0×	100 0.4×	191 1.0×	130 0.7×	60	703
Jiwang Liang China	14	76 0.2×	122 0.4×	305 1.1×	195 1.0×	155 0.8×	24	658
Mridula Shukla India	12	70 0.2×	160 0.5×	171 0.6×	99 0.5×	143 0.8×	30	453
N Tradati Italy	12	170 0.4×	121 0.4×	175 0.6×	50 0.3×	107 0.6×	20	480
Dory Sample United States	8	228 0.6×	239 0.7×	174 0.6×	45 0.2×	161 0.9×	12	544
Roland Kurdow Germany	11	37 0.1×	224 0.7×	253 0.9×	395 2.1×	167 0.9×	22	699
E. Mickiewicz Argentina	9	98 0.3×	372 1.2×	99 0.4×	166 0.9×	72 0.4×	15	639
Ken Saijo Japan	12	68 0.2×	232 0.7×	92 0.3×	133 0.7×	203 1.1×	47	530
Jean‐Nicolas Gallant United States	13	30 0.1×	155 0.5×	137 0.5×	142 0.8×	192 1.0×	43	580

Countries citing papers authored by Musa Altun

Since Specialization

Citations

This map shows the geographic impact of Musa Altun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Musa Altun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Musa Altun more than expected).

Fields of papers citing papers by Musa Altun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Musa Altun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Musa Altun. The network helps show where Musa Altun may publish in the future.

Co-authorship network of co-authors of Musa Altun

This figure shows the co-authorship network connecting the top 25 collaborators of Musa Altun. A scholar is included among the top collaborators of Musa Altun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Musa Altun. Musa Altun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karadeniz, Ahmet, et al.. (2023). Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort. Journal of Chemotherapy. 36(2). 133–142. 1 indexed citations

Kebudi, Rejin, et al.. (2021). Nasopharyngeal carcinoma in children: Multimodal treatment and long‐term outcome of 92 patients in a single center over a 28‐year period. Pediatric Blood & Cancer. 68(12). e29372–e29372. 5 indexed citations

Bilge, Hatice, et al.. (2018). Nasopharyngeal carcinoma radiotherapy with hybrid technique. Medical dosimetry. 44(3). 251–257. 12 indexed citations

Karaman, Şule, et al.. (2018). [P251] Dosimetric impact of intermediate dose calculation on heterogeneous region radiotherapy planning. Physica Medica. 52. 171–171.

Fayda, Merdan, Mustafa Işın, Makbule Tambaş, et al.. (2015). Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?. Tumor Biology. 37(3). 3969–3978. 64 indexed citations

Altun, Musa, et al.. (2015). Radiation Dose to Hippocampus With Increasing Planning Target Volume in Patients With Pituitary Adenoma Treated With Hypofractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 93(3). E83–E84. 1 indexed citations

Karakoyun-Çelik, Ömür, et al.. (2014). Practice patterns for oropharyngeal cancer in radiation oncology centers of Turkey.. PubMed. 100(3). 284–8.

Veyseller, Bayram, et al.. (2014). Olfactory bulb volume and olfactory function after radiotherapy in patients with nasopharyngeal cancer. Auris Nasus Larynx. 41(5). 436–440. 14 indexed citations

Odabaş, Hatice, Makbule Tambaş, Leyla Kılıç, et al.. (2014). Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma. Tumor Biology. 36(2). 1039–1044. 5 indexed citations

10.

Kayhan, Kıvanç Bektaş, et al.. (2014). Carcinoma of the Tongue: A Case-control Study on Etiologic Factors and Dental Trauma. Asian Pacific Journal of Cancer Prevention. 15(5). 2225–2229. 13 indexed citations

11.

Ekenel, Meltem, Serkan Keskın, Mert Başaran, et al.. (2011). Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma. Oral Oncology. 47(7). 660–664. 22 indexed citations

12.

Fayda, Merdan, Görkem Aksu, Fulya Ağaoğlu, et al.. (2008). The role of surgery and radiotherapy in treatment of soft tissue sarcomas of the head and neck region: Review of 30 cases. Journal of Cranio-Maxillofacial Surgery. 37(1). 42–48. 38 indexed citations

13.

Ağaoğlu, Fulya, Yavuz Dizdar, Öner Doğan, et al.. (2005). P53 overexpression in nasopharyngeal carcinoma.. PubMed. 18(5). 555–60. 24 indexed citations

14.

Onat, Haluk, Mert Başaran, Sevil Bavbek, et al.. (2002). High-dose Epirubicin and Cisplatin in Locally Advanced Undifferentiated Nasopharyngeal Carcinoma. Clinical Oncology. 14(6). 449–454. 7 indexed citations

15.

Başaran, Mert, Sevil Bavbek, İbrahim Güllü, et al.. (2002). A Phase II Study of Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent or Metastatic Head and Neck Cancer. Journal of Chemotherapy. 14(2). 207–213. 22 indexed citations

16.

Yazıcı, Hülya, Musa Altun, Günter Hafız, & Nejat Dalay. (2001). Serum and Tissue c-erb B2, bcl-2, and Mutant p53 Oncoprotein Levels in Nasopharyngeal Cancer. Cancer Investigation. 19(8). 773–778. 1 indexed citations

17.

Yazıcı, Hülya, Musa Altun, Canan Alatlı, Öner Doğan, & Nejat Dalay. (2000). c-erbB-2 Gene Amplification in Nasopharyngeal Carcinoma. Cancer Investigation. 18(1). 6–10. 24 indexed citations

18.

Altun, Musa, et al.. (2000). Locally advanced nasopharyngeal carcinoma: computed tomography findings, clinical evaluation, and treatment outcome∗. International Journal of Radiation Oncology*Biology*Physics. 47(2). 401–404. 13 indexed citations

19.

Karahasanoğlu, Tayfun, et al.. (1997). Giant Intra-abdominal Esophageal Duplication Cyst. Endoscopy. 29(9). S 54–S 55. 8 indexed citations

20.

Fandi, Abderrahim, et al.. (1994). Nasopharyngeal cancer: epidemiology, staging, and treatment.. PubMed. 21(3). 382–97. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact